Skip to main content

What the FDA labels say about taking them together

Candesartan/hydrochlorothiazide and digoxin

Candesartan/hydrochlorothiazide's FDA label of December 22, 2025 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name candesartan/hydrochlorothiazide. The candesartan/hydrochlorothiazide label: “Digitalis − Thiazide-induced hypokalemia or hypomagnesemia may predispose to digoxin toxicity.”

Check it at the source: the candesartan/hydrochlorothiazide FDA label on DailyMed (effective December 22, 2025, ANI Pharmaceuticals, Inc.); the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the candesartan/hydrochlorothiazide label say about digoxin?

Candesartan/hydrochlorothiazide label, drug interactions

Digitalis − Thiazide-induced hypokalemia or hypomagnesemia may predispose to digoxin toxicity.

Source: FDA drug label (Candesartan Cilexetil and Hydrochlorothiazide), NDA021093 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective December 22, 2025 (SPL set bd8d318d-167a-4b26-935d-265dde3193de), via openFDA; the full label on DailyMed

What does the digoxin label say about candesartan/hydrochlorothiazide?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name candesartan/hydrochlorothiazide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

4Candesartan/hydrochlorothiazide generic labelers
26Digoxin generic labelers
Candesartan/hydrochlorothiazideDigoxin
Labeled forHigh blood pressureHeart failure, Atrial fibrillation
Boxed warningYesNo
Pharmacy cost (NADAC)$0.954 per tablet 16-12.5 mg tablet$0.133 per tablet 125 mcg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?